Insights

Clinical Stage Focus INOVIO is a clinical stage biotechnology company concentrating on DNA medicines for HPV-related diseases, cancer, and infectious diseases, presenting opportunities for partnerships in early-stage clinical development, contract research, and co-development with larger pharma players seeking DNA vaccine/therapy capabilities.

DNA Medicine Platform The company’s emphasis on DNA-based therapies including the Cellectra device platform and VGX-3100 vaccine candidate suggests potential sales avenues in device procurement, regulatory-focused collaboration, and integration of DNA delivery technologies into partner programs.

Manufacturing & Compliance Recent reports of manufacturing deficiencies highlight a potential need for manufacturing optimization, quality systems enhancement, and supply chain partnerships to stabilize production for clinical and eventual commercial doses, creating opportunities for CDMO or quality consulting engagements.

Financial & Legal Signals Low current revenue with ongoing funding and multiple securities lawsuits may drive BI/BD teams to propose risk-sharing collaborations, milestone-based partnerships, or equity-linked financing discussions to support pipeline advancement while addressing investor concerns.

Strategic Collaborations Recent clinical collaboration with Akeso for immunotherapy combos indicates openness to co-development arrangements; this could be extended to explore strategic alliances with oncology platforms, imaging/biomarker partners, or regional manufacturing hubs to accelerate trials and broaden reach.

INOVIO Pharmaceuticals, Inc. Tech Stack

INOVIO Pharmaceuticals, Inc. uses 8 technology products and services including CompTIA Security+, ISO, ISO 13485, and more. Explore INOVIO Pharmaceuticals, Inc.'s tech stack below.

CompTIA Security+

Certificates

ISO

Certificates

ISO 13485

Certificates

gstatic.com

Content Delivery Network

git

Development

Highstock

Javascript Graphics

PowerShell

Security

Adobe Fonts

Web Fonts

INOVIO Pharmaceuticals, Inc. Email Formats	Example	Percentage
First.Last@inovio.com	John.Doe@inovio.com	64%
FLast@inovio.com	JDoe@inovio.com	29%
Last@inovio.com	Doe@inovio.com	5%
FirstLast@inovio.com	JohnDoe@inovio.com	2%

INOVIO Pharmaceuticals, Inc. Email Formats

Example

Percentage

First.Last@inovio.com

John.Doe@inovio.com

64%

FLast@inovio.com

JDoe@inovio.com

29%

Last@inovio.com

Doe@inovio.com

FirstLast@inovio.com

JohnDoe@inovio.com

Frequently Asked Questions

What is INOVIO Pharmaceuticals, Inc.'s phone number?

You can contact INOVIO Pharmaceuticals, Inc.'s main corporate office by phone at

+1-877-446-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is INOVIO Pharmaceuticals, Inc.'s stock symbol?

INOVIO Pharmaceuticals, Inc. is a publicly traded company; the company's stock symbol is INO.

What is INOVIO Pharmaceuticals, Inc.'s official website and social media links?

INOVIO Pharmaceuticals, Inc.'s official website is inovio.com and has social profiles on LinkedIn Crunchbase.

What is INOVIO Pharmaceuticals, Inc.'s SIC code NAICS code?

INOVIO Pharmaceuticals, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does INOVIO Pharmaceuticals, Inc. have currently?

As of July 2026, INOVIO Pharmaceuticals, Inc. has approximately 200 employees across 5 continents, including North AmericaAsiaEurope. Key team members include Chief Medical Officer: M. B.Vice President Clinical Development: M. G.Owner On Long Vacation: B. V.. Explore INOVIO Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does INOVIO Pharmaceuticals, Inc. belong to?

INOVIO Pharmaceuticals, Inc. operates in the Biotechnology Research industry.

What technology does INOVIO Pharmaceuticals, Inc. use?

INOVIO Pharmaceuticals, Inc.'s tech stack includes CompTIA Security+ISOISO 13485gstatic.comgitHighstockPowerShellAdobe Fonts.

What is INOVIO Pharmaceuticals, Inc.'s email format?

INOVIO Pharmaceuticals, Inc.'s email format typically follows the pattern of First.Last@inovio.com. Find more INOVIO Pharmaceuticals, Inc. email formats with LeadIQ.

How much funding has INOVIO Pharmaceuticals, Inc. raised to date?

As of July 2026, INOVIO Pharmaceuticals, Inc. has raised $25M in funding. for $25M.

INOVIO Pharmaceuticals, Inc.

Q: What technology does INOVIO Pharmaceuticals, Inc. use?

INOVIO Pharmaceuticals, Inc.'s tech stack includes Microsoft Outlook, AddThis, OWL Carousel, Zerto, Slider Revolution.

Q: How much funding has INOVIO Pharmaceuticals, Inc. raised to date?

INOVIO Pharmaceuticals, Inc. has raised $25M in funding for $25M.

Q: What is INOVIO Pharmaceuticals, Inc.'s NAICS code?

INOVIO Pharmaceuticals, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchPennsylvania, United States51-200 Employees

INOVIO Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to treat or protect people from HPV-related diseases, cancer, and infectious diseases. Its work centers on advancing DNA-based therapies with the goal of benefiting patients worldwide. The company is based in Plymouth Meeting, Pennsylvania, and operates within the biotechnology research industry. 

The company is described as mid-sized, with a workforce in the hundreds. A recent development involves a collaboration with Akeso to evaluate a novel immunotherapy for glioblastoma, reflecting ongoing clinical partnerships. Public reports have also noted manufacturing deficiencies associated with its CELLECTRA device.

Insights

Similar companies to INOVIO Pharmaceuticals, Inc.

Sanofi

Johnson & Johnson